ALNYLAM PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALNYLAM PHARMACEUTICALS, INC. has filed 1,657 SEC EDGAR filings since 09 Jul 2002

SEC filing history

Showing 51-75 of 207 matching filings.

Per page
25
Current page
3
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
29 Apr 2021
Reporting date
29 Apr 2021
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
11 Feb 2021
Reporting date
11 Feb 2021
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
05 Nov 2020
Reporting date
05 Nov 2020
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
06 Aug 2020
Reporting date
03 Aug 2020
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
06 May 2020
Reporting date
06 May 2020
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
06 Feb 2020
Reporting date
06 Feb 2020
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
31 Oct 2019
Reporting date
31 Oct 2019
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .